113 related articles for article (PubMed ID: 8332121)
1. [Experimental studies on the relation of platelet activating factor (PAF) to high mortality in sublethal endotoxemia after massive hepatectomy and effects of its antagonist].
Onuki Y; Nakamura S; Muro H; Baba S
Nihon Geka Gakkai Zasshi; 1993 May; 94(5):466-74. PubMed ID: 8332121
[TBL] [Abstract][Full Text] [Related]
2. [Effects of sublethal endotoxemia to the hepatic reticuloendothelial system after massive hepatectomy].
Maruo H; Nakamura S; Muro H
Nihon Geka Gakkai Zasshi; 1991 Nov; 92(11):1608-16. PubMed ID: 1770933
[TBL] [Abstract][Full Text] [Related]
3. A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery.
Ono S; Mochizuki H; Tamakuma S
Am J Surg; 1996 Apr; 171(4):409-15. PubMed ID: 8604832
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in rats.
Balsa D; Merlos M; Giral M; Ferrando R; Garcia-Rafanell J; Forn J
Drugs Exp Clin Res; 1997; 23(5-6):191-9. PubMed ID: 9515229
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
[TBL] [Abstract][Full Text] [Related]
6. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
Rabinovici R; Yue TL; Farhat M; Smith EF; Esser KM; Slivjak M; Feuerstein G
J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560
[TBL] [Abstract][Full Text] [Related]
7. ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious rats.
Albert DH; Luo G; Magoc TJ; Tapang P; Holms JH; Davidsen SK; Summers JB; Carter GW
Shock; 1996 Aug; 6(2):112-7. PubMed ID: 8856845
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of endotoxin-induced increase in glucose metabolism by platelet-activating factor antagonist.
Lang CH; Dobrescu C; Hargrove DM; Bagby GJ; Spitzer JJ
Circ Shock; 1987; 23(3):179-88. PubMed ID: 3427772
[TBL] [Abstract][Full Text] [Related]
9. Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats.
Natsume Y; Imanishi N; Koike H; Morooka S
Arzneimittelforschung; 1994 Nov; 44(11):1208-13. PubMed ID: 7848333
[TBL] [Abstract][Full Text] [Related]
10. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
Toth PD; Mikulaschek AW
Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
[TBL] [Abstract][Full Text] [Related]
12. [Pathogenetic effect of platelet activating factor on enterogenic endotoxemia after burn].
Yu P; Xiao G; Fu W
Zhonghua Yi Xue Za Zhi; 1999 Feb; 79(2):136-8. PubMed ID: 11601022
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
Nagaoka J; Harada K; Kimura A; Kobayashi S; Murakami M; Yoshimura T; Yamada K; Asano O; Katayama K; Yamatsu I
Arzneimittelforschung; 1991 Jul; 41(7):719-24. PubMed ID: 1663352
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and experimental studies of septic DIC in surgical patients, in terms of its characteristic features and pathogenesis].
Ono S
Nihon Geka Gakkai Zasshi; 1994 Dec; 95(12):849-59. PubMed ID: 7877583
[TBL] [Abstract][Full Text] [Related]
15. Liver and plasma concentrations in paf-acether and its precursors after partial hepatectomy.
Lombard MN; Izzo AA; Benhaddi M; Natour J; Benveniste J
Cell Prolif; 1996 Jan; 29(1):33-41. PubMed ID: 8603108
[TBL] [Abstract][Full Text] [Related]
16. The role of platelet-activating factor in conscious, normotensive endotoxemia.
Ephgrave K; Kremer T; Broadhurst K; Cullen J
J Surg Res; 1997 Mar; 68(2):170-4. PubMed ID: 9184676
[TBL] [Abstract][Full Text] [Related]
17. Potential etiologic role of PAF in two major septic complications; disseminated intravascular coagulation and multiple organ failure.
Ou MC; Kambayashi J; Kawasaki T; Uemura Y; Shinozaki K; Shiba E; Sakon M; Yukawa M; Mori T
Thromb Res; 1994 Feb; 73(3-4):227-38. PubMed ID: 8191415
[TBL] [Abstract][Full Text] [Related]
18. Role of platelet activating factor in development of thrombocytopenia and neutropenia in dogs with endotoxemia.
Tsuchiya R; Kyotani K; Scott MA; Nishizono K; Ashida Y; Mochizuki T; Kitao S; Yamada T; Kobayashi K
Am J Vet Res; 1999 Feb; 60(2):216-21. PubMed ID: 10048555
[TBL] [Abstract][Full Text] [Related]
19. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure.
Anderson BO; Bensard DD; Harken AH
Surg Gynecol Obstet; 1991 May; 172(5):415-24. PubMed ID: 1851337
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor (TNF) and endotoxin prime effects of PAF in vivo.
Heuer HO; Letts G; Meade CJ
J Lipid Mediat; 1990; 2 Suppl():S101-8. PubMed ID: 2133276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
